Acurx Pharmaceuticals, Inc (ACXP) insider trading
Every open-market stock purchase and sale by Acurx Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: David P Luci (CEO), n/a, 21 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ACXP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Apr 20, 2026 | Robert J Deluccia (Director) | Bought (not open market) | — |
| Apr 20, 2026 | Carl Sailer (Director) | Bought (not open market) | — |
| Apr 20, 2026 | Jack H Dean (Director) | Bought (not open market) | — |
| Apr 20, 2026 | Robert G. Shawah (CFO) | Bought (not open market) | — |
| Apr 20, 2026 | David P Luci (CEO) | Bought (not open market) | — |
| Apr 20, 2026 | James J. Donohue (Director) | Bought (not open market) | — |
| Apr 20, 2026 | Thomas L Harrison (Director) | Bought (not open market) | — |
| Apr 20, 2026 | Joseph C Scodari (Director) | Bought (not open market) | — |
Who's trading ACXP
- Jack H Dean, Director: other filings, last Apr 20, 2026
- Robert J Deluccia, 10% owner: other filings, last Apr 20, 2026
- James J. Donohue, Director: other filings, last Apr 20, 2026
- Thomas L Harrison, Director: other filings, last Apr 20, 2026
- David P Luci, CEO: other filings, last Apr 20, 2026
- Carl Sailer, Director: other filings, last Apr 20, 2026
- Joseph C Scodari, Director: other filings, last Apr 20, 2026
- Robert G. Shawah, CFO: other filings, last Apr 20, 2026
Get free alerts when an insider at Acurx Pharmaceuticals, Inc files a new trade →